The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Rofecoxib-Global Market Insights and Sales Trends 2024
Synopsis
Rofecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain conditions, migraine, and dysmenorrhea.Rofecoxib was available by prescription in both tablet-form and as an oral suspension.
The global Rofecoxib market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Rofecoxib in various end use industries. The expanding demands from the Osteoarthritis, Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis and Acute Pain Conditions, are propelling Rofecoxib market. Oral Suspension., one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tablet-Form segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Rofecoxib market, driven by demand from China, the second largest economy with some signs of stabilising, the Rofecoxib market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Rofecoxib, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Rofecoxib market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Rofecoxib market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Rofecoxib sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Rofecoxib covered in this report include Merck, Chengdu Meinkai Chemical Co. LTD, Wuhan Xinxin Jiali Biotechnology Co. LTD, Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD, Pfizer and Tremeau, etc.
The global Rofecoxib market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Chengdu Meinkai Chemical Co. LTD
Wuhan Xinxin Jiali Biotechnology Co. LTD
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Pfizer
Tremeau
Global Rofecoxib market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Rofecoxib market, Segment by Type:
Oral Suspension.
Tablet-Form
Global Rofecoxib market, by Application
Osteoarthritis
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Acute Pain Conditions
Migraine
Dysmenorrhea
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Rofecoxib manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Rofecoxib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Rofecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain conditions, migraine, and dysmenorrhea.Rofecoxib was available by prescription in both tablet-form and as an oral suspension.
The global Rofecoxib market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Rofecoxib in various end use industries. The expanding demands from the Osteoarthritis, Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis and Acute Pain Conditions, are propelling Rofecoxib market. Oral Suspension., one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tablet-Form segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Rofecoxib market, driven by demand from China, the second largest economy with some signs of stabilising, the Rofecoxib market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Rofecoxib, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Rofecoxib market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Rofecoxib market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Rofecoxib sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Rofecoxib covered in this report include Merck, Chengdu Meinkai Chemical Co. LTD, Wuhan Xinxin Jiali Biotechnology Co. LTD, Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD, Pfizer and Tremeau, etc.
The global Rofecoxib market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Chengdu Meinkai Chemical Co. LTD
Wuhan Xinxin Jiali Biotechnology Co. LTD
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Pfizer
Tremeau
Global Rofecoxib market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Rofecoxib market, Segment by Type:
Oral Suspension.
Tablet-Form
Global Rofecoxib market, by Application
Osteoarthritis
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Acute Pain Conditions
Migraine
Dysmenorrhea
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Rofecoxib manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Rofecoxib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Rofecoxib Market Overview
1.1 Rofecoxib Product Overview
1.2 Rofecoxib Market Segment by Type
1.2.1 Oral Suspension.
1.2.2 Tablet-Form
1.3 Global Rofecoxib Market Size by Type
1.3.1 Global Rofecoxib Market Size Overview by Type (2018-2029)
1.3.2 Global Rofecoxib Historic Market Size Review by Type (2018-2023)
1.3.3 Global Rofecoxib Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Rofecoxib Sales Breakdown by Type (2018-2023)
1.4.2 Europe Rofecoxib Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Rofecoxib Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Rofecoxib Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Rofecoxib Sales Breakdown by Type (2018-2023)
2 Global Rofecoxib Market Competition by Company
2.1 Global Top Players by Rofecoxib Sales (2018-2023)
2.2 Global Top Players by Rofecoxib Revenue (2018-2023)
2.3 Global Top Players by Rofecoxib Price (2018-2023)
2.4 Global Top Manufacturers Rofecoxib Manufacturing Base Distribution, Sales Area, Product Type
2.5 Rofecoxib Market Competitive Situation and Trends
2.5.1 Rofecoxib Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Rofecoxib Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rofecoxib as of 2022)
2.7 Date of Key Manufacturers Enter into Rofecoxib Market
2.8 Key Manufacturers Rofecoxib Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Rofecoxib Status and Outlook by Region
3.1 Global Rofecoxib Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Rofecoxib Historic Market Size by Region
3.2.1 Global Rofecoxib Sales in Volume by Region (2018-2023)
3.2.2 Global Rofecoxib Sales in Value by Region (2018-2023)
3.2.3 Global Rofecoxib Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Rofecoxib Forecasted Market Size by Region
3.3.1 Global Rofecoxib Sales in Volume by Region (2024-2029)
3.3.2 Global Rofecoxib Sales in Value by Region (2024-2029)
3.3.3 Global Rofecoxib Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Rofecoxib by Application
4.1 Rofecoxib Market Segment by Application
4.1.1 Osteoarthritis
4.1.2 Rheumatoid Arthritis
4.1.3 Juvenile Rheumatoid Arthritis
4.1.4 Acute Pain Conditions
4.1.5 Migraine
4.1.6 Dysmenorrhea
4.2 Global Rofecoxib Market Size by Application
4.2.1 Global Rofecoxib Market Size Overview by Application (2018-2029)
4.2.2 Global Rofecoxib Historic Market Size Review by Application (2018-2023)
4.2.3 Global Rofecoxib Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Rofecoxib Sales Breakdown by Application (2018-2023)
4.3.2 Europe Rofecoxib Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Rofecoxib Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Rofecoxib Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Rofecoxib Sales Breakdown by Application (2018-2023)
5 North America Rofecoxib by Country
5.1 North America Rofecoxib Historic Market Size by Country
5.1.1 North America Rofecoxib Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Rofecoxib Sales in Volume by Country (2018-2023)
5.1.3 North America Rofecoxib Sales in Value by Country (2018-2023)
5.2 North America Rofecoxib Forecasted Market Size by Country
5.2.1 North America Rofecoxib Sales in Volume by Country (2024-2029)
5.2.2 North America Rofecoxib Sales in Value by Country (2024-2029)
6 Europe Rofecoxib by Country
6.1 Europe Rofecoxib Historic Market Size by Country
6.1.1 Europe Rofecoxib Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Rofecoxib Sales in Volume by Country (2018-2023)
6.1.3 Europe Rofecoxib Sales in Value by Country (2018-2023)
6.2 Europe Rofecoxib Forecasted Market Size by Country
6.2.1 Europe Rofecoxib Sales in Volume by Country (2024-2029)
6.2.2 Europe Rofecoxib Sales in Value by Country (2024-2029)
7 Asia-Pacific Rofecoxib by Region
7.1 Asia-Pacific Rofecoxib Historic Market Size by Region
7.1.1 Asia-Pacific Rofecoxib Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Rofecoxib Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Rofecoxib Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Rofecoxib Forecasted Market Size by Region
7.2.1 Asia-Pacific Rofecoxib Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Rofecoxib Sales in Value by Region (2024-2029)
8 Latin America Rofecoxib by Country
8.1 Latin America Rofecoxib Historic Market Size by Country
8.1.1 Latin America Rofecoxib Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Rofecoxib Sales in Volume by Country (2018-2023)
8.1.3 Latin America Rofecoxib Sales in Value by Country (2018-2023)
8.2 Latin America Rofecoxib Forecasted Market Size by Country
8.2.1 Latin America Rofecoxib Sales in Volume by Country (2024-2029)
8.2.2 Latin America Rofecoxib Sales in Value by Country (2024-2029)
9 Middle East and Africa Rofecoxib by Country
9.1 Middle East and Africa Rofecoxib Historic Market Size by Country
9.1.1 Middle East and Africa Rofecoxib Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Rofecoxib Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Rofecoxib Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Rofecoxib Forecasted Market Size by Country
9.2.1 Middle East and Africa Rofecoxib Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Rofecoxib Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Rofecoxib Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Rofecoxib Products Offered
10.1.5 Merck Recent Development
10.2 Chengdu Meinkai Chemical Co. LTD
10.2.1 Chengdu Meinkai Chemical Co. LTD Company Information
10.2.2 Chengdu Meinkai Chemical Co. LTD Introduction and Business Overview
10.2.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Chengdu Meinkai Chemical Co. LTD Rofecoxib Products Offered
10.2.5 Chengdu Meinkai Chemical Co. LTD Recent Development
10.3 Wuhan Xinxin Jiali Biotechnology Co. LTD
10.3.1 Wuhan Xinxin Jiali Biotechnology Co. LTD Company Information
10.3.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Introduction and Business Overview
10.3.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Products Offered
10.3.5 Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Development
10.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
10.4.1 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Company Information
10.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Introduction and Business Overview
10.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Products Offered
10.4.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Rofecoxib Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Pfizer Rofecoxib Products Offered
10.5.5 Pfizer Recent Development
10.6 Tremeau
10.6.1 Tremeau Company Information
10.6.2 Tremeau Introduction and Business Overview
10.6.3 Tremeau Rofecoxib Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Tremeau Rofecoxib Products Offered
10.6.5 Tremeau Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Rofecoxib Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Rofecoxib Industrial Chain Analysis
11.4 Rofecoxib Market Dynamics
11.4.1 Rofecoxib Industry Trends
11.4.2 Rofecoxib Market Drivers
11.4.3 Rofecoxib Market Challenges
11.4.4 Rofecoxib Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Rofecoxib Distributors
12.3 Rofecoxib Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
